Recent Submissions

  • Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial 

    Younossi, ZM; Ratziu, V; Loomba, R; Rinella, M; Anstee, QM; Goodman, Z; Bedossa, P; Geier, A; Beckebaum, S; Newsome, PN; Sheridan, D; Sheikh, MY; Trotter, J; Knapple, W; Lawitz, E; Abdelmalek, MF; Kowdley, KV; Montano-Loza, AJ; Boursier, J; Mathurin, P; Bugianesi, E; Mazzella, G; Olveira, A; Cortez-Pinto, H; Graupera, I; Orr, D; Gluud, LL; Dufour, J-F; Shapiro, D; Campagna, J; Zaru, L; MacConell, L; Shringarpure, R; Harrison, S; Sanyal, AJ; Abdelmalek, M; Abrams, G; Aguilar, H; Ahmed, A; Aigner, E; Aithal, G; Ala, A; Alazawi, W; Albillos, A; Allison, M; Al-Shamma, S; Andrade, R; Andreone, P; Angelico, M; Ankoma-Sey, V; Anstee, Q; Anty, R; Araya, V; Arenas Ruiz, JI; Arkkila, P; Arora, M; Asselah, T; Au, J; Ayonrinde, O; Bailey, RJ; Balakrishnan, M; Bambha, K; Bansal, M; Barritt, S; Bate, J; Beato, J; Beckebaum, S; Behari, J; Bellot, P; Ben Ari, Z; Bennett, M; Berenguer, M; Beretta-Piccoli, BT; Berg, T; Bonacini, M; Bonet, L; Borg, B; Bourliere, M; Boursier, J; Bowman, W; Bradley, D; Brankovic, M; Braun, M; Bronowicki, J-P; Bruno, S; Bugianesi, E; Cai, C; Calleja Panero, JL; Carey, E; Carmiel, M; Carrión, JA; Cave, M; Chagas, C; Chami, T; Chang, A; Coates, A; Cobbold, J; Corey, K; Corless, L; Cortez-Pinto, H; Crespo, J; Cruz Pereira, O; de Ledinghen, V; deLemos, A; Diago, M; Dufour, J-F; Dugalic, P; Dunn, W; Elkhashab, M; Epstein, M; Escudero-Garcia, MD; Etzion, O; Evans, L; Falcone, R; Fernandez, C; Ferreira, J; Fink, S; Finnegan, K; Firpi-Morell, R; Floreani, A; Fontanges, T; Ford, R; Forrest, E; Fowell, A; Fracanzani, AL; Francque, S; Freilich, B; Frias, J; Fuchs, M; Fuentes, J; Galambos, M; Gallegos, J; Geerts, A; Geier, A; George, J; Ghali, M; Ghalib, R; Gholam, P; Gines, P; Gitlin, N; Gluud, LL; Goeser, T; Goff, J; Gordon, S; Gordon, F; Goria, O; Greer, S; Grigorian, A; Gronbaek, H; Guillaume, M; Gunaratnam, N; Halegoua-De Marzio, D; Hameed, B; Hametner, S; Hamilton, J; Harrison, S; Hartleb, M; Hassanein, T; Häussinger, D; Hellstern, P; Herring, R; Heurich, E; Hezode, C; Hinrichsen, H; Holland Fischer, P; Horsmans, Y; Huang, J; Jakiche, A; Jeffers, L; Jones, B; Jorge, R; Jorquera, F; Kahraman, A; Kaita, K; Karyotakis, N; Kayali, Z; Kechagias, S; Kepczyk, T; Khalili, M; Khallafi, H; Kluwe, J; Knapple, W; Kohli, A; Korenblat, K; Kowdley, K; Krag, A; Krause, R; Kremer, A; Krok, K; Krstic, M; Kugelmas, M; Kumar, S; Labarriere, D; Lai, M; Lampertico, P; Lawitz, E; Lee, A; Leroy, V; Lidofsky, S; Lim, TH; Lim, J; Lipkis, D; Little, E; Lonardo, A; Long, M; Loomba, R; Lurie, Y; Macedo, G; Makara, M; Maliakkal, B; Manns, M; Manousou, P; Mantry, P; Marchesini, G; Marinho, C; Marotta, P; Marschall, H-U; Mathurin, P; Mayo, M; Mazzella, G; McCullen, M; McLaughlin, W; Merriman, R; Modi, A; Molina, E; Montano-Loza, A; Monteverde, C; Moreea, S; Moreno, C; Morisco, F; Mubarak, A; Muellhaupt, B; Mukherjee, S; Müller, T; Nagorni, A; Naik, J; Neff, G; Nevah, M; Newsome, P; Nguyen-Khac, E; Noureddin, M; Oben, J; Olveira, A; Orlent, H; Orr, D; Orr, J; Ortiz-Lasanta, G; Ozenne, V; Pandya, P; Paredes, A; Park, J; Patel, J; Patel, K; Uta, M; Patton, H; Peck-Radosavljevic, M; Petta, S; Pianko, S; Piekarska, A; Pimstone, N; Pockros, P; Pol, S; Porayko, M; Poulos, J; Pound, D; Pouzar, J; Presa Ramos, J; Pyrsopoulos, N; Rafiq, N; Muller, K; Ramji, A; Ratziu, V; Ravinuthala, R; Reddy, C; Reddy K G, G; Reddy K R, KR; Regenstein, F; Reindollar, R; Riera, A; Rinella, M; Rivera Acosta, J; Robaeys, G; Roberts, S; Rodriguez-Perez, F; Romero-Gomez, M; Rubin, R; Rumi, M; Rushbrook, S; Rust, C; Ryan, M; Safadi, R; Said, A; Salminen, K; Samuel, D; Santoro, J; Sanyal, A; Sarkar, S; Schaeffer, C; Schattenberg, J; Schiefke, I; Schiff, E; Schmidt, W; Schneider, J; Schouten, J; Schultz, M; Sebastiani, G; Semela, D; Sepe, T; Sheikh, A; Sheikh, M; Sheridan, D; Sherman, K; Shibolet, O; Shiffman, M; Siddique, A; Sieberhagen, C; Sigal, S; Sikorska, K; Simon, K; Sinclair, M; Skoien, R; Solis, J; Sood, S; Souder, B; Spivey, J; Stal, P; Stinton, L; Strasser, S; Svorcan, P; Szabo, G; Talal, A; Tam, E; Tetri, B; Thuluvath, P; Tobias, H; Tomasiewicz, K; Torres, D; Trauner, M; Trautwein, C; Trotter, J; Tsochatzis, E; Unitt, E; Vargas, V; Varkonyi, I; Veitsman, E; Vespasiani Gentilucci, U; Victor, D; Vierling, J; Vincent, C; Vincze, A; von der Ohe, M; Von Roenn, N; Vuppalanchi, R; Waters, M; Watt, K; Weltman, M; Wieland, A; Wiener, G; Williams A, A; Williams J, J; Wilson, J; Yataco, M; Yoshida, E; Younes, Z; Yuan, L; Zivony, A; Zogg, D; Zoller, H; Zoulim, F; Zuckerman, E; Zuin, M (Elsevier BV, 2019-12)
  • Comparative costs and activity from a sample of UK clinical trials units 

    Hind, D; Reeves, BC; Bathers, S; Bray, C; Corkhill, A; Hayward, C; Harper, L; Napp, V; Norrie, J; Speed, C; Tremain, L; Keat, N; Bradburn, M (Springer Science and Business Media LLC, 2017-12)
  • Postpartum Regression of a Presumed Cavernous Meningioma. 

    Phang, SY; Whitfield, P (United States, 2016)
    Meningiomas are known to be more common in females than males. They are also known in rare cases to grow in size during pregnancy, which can complicate its management. We describe a 31-year-old Caucasian woman who presented ...
  • Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trial. 

    Kolias, AG; Edlmann, E; Thelin, EP; Bulters, D; Holton, P; Suttner, N; Owusu-Agyemang, K; Al-Tamimi, YZ; Gatt, D; Thomson, S; Anderson, IA; Richards, O; Whitfield, P; Gherle, M; Caldwell, K; Davis-Wilkie, C; Tarantino, S; Barton, G; Marcus, HJ; Chari, A; Brennan, P; Belli, A; Bond, S; Turner, C; Whitehead, L; Wilkinson, I; Hutchinson, PJ; British Neurosurgical Trainee Research Collaborative (BNTRC) and Dex-CSDH Trial Collaborators (England, 2018-12-04)
    BACKGROUND: Chronic subdural haematoma (CSDH) is a common neurosurgical condition, typically treated with surgical drainage of the haematoma. However, surgery is associated with mortality and morbidity, including up to ...
  • Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy. 

    Edlmann, E; Giorgi-Coll, S; Whitfield, PC; Carpenter, KLH; Hutchinson, PJ (England, 2017-05-30)
    Chronic subdural haematoma (CSDH) is an encapsulated collection of blood and fluid on the surface of the brain. Historically considered a result of head trauma, recent evidence suggests there are more complex processes ...
  • Dex-CSDH randomised, placebo-controlled trial of dexamethasone for chronic subdural haematoma: report of the internal pilot phase. 

    Edlmann, E; Thelin, EP; Caldwell, K; Turner, C; Whitfield, P; Bulters, D; Holton, P; Suttner, N; Owusu-Agyemang, K; Al-Tamimi, YZ; Gatt, D; Thomson, S; Anderson, IA; Richards, O; Gherle, M; Toman, E; Nandi, D; Kane, P; Pantaleo, B; Davis-Wilkie, C; Tarantino, S; Barton, G; Marcus, HJ; Chari, A; Belli, A; Bond, S; Gafoor, R; Dawson, S; Whitehead, L; Brennan, P; Wilkinson, I; Kolias, AG; Hutchinson, PJA; Dex-CSDH trial collaborative and BNTRC collaborative. (England, 2019-04-10)
    The Dex-CSDH trial is a randomised, double-blind, placebo-controlled trial of dexamethasone for patients with a symptomatic chronic subdural haematoma. The trial commenced with an internal pilot, whose primary objective ...

View more


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
@mire NV